71 – 80 of 124
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
FCGAMMARIIB Inhibits The Development Of Atherosclerosis In Mice
(
- Contribution to journal › Published meeting abstract
-
Mark
Apob-100 Peptide Immunization Reduce Macrophage Plaque Infiltration In Apobec1-/- Ldlr-/- Mice With Advanced Atherosclerotic Lesions
(
- Contribution to journal › Published meeting abstract
-
Mark
Effects of simvastatin on circulating autoantibodies to oxidized LDL antigens: relation with immune stimulation markers.
(
- Contribution to journal › Article
-
Mark
Evidence Of A Role Of T Regulatory Cells Mediating Atheroprotection By APO B 100 Peptide Immunization
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.885-885(
- Contribution to journal › Published meeting abstract
-
Mark
Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
Associations Between Human Leukocyte Antigen (HLA) Genotype And Acute Myocardial Infarction
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.953-953(
- Contribution to journal › Published meeting abstract
-
Mark
Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions.
(
- Contribution to journal › Article
-
Mark
Atheroprotective Effects of Alum Are Associated With Capture of Oxidized LDL Antigens and Activation of Regulatory T Cells.
(
- Contribution to journal › Article
-
Mark
Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes.
(
- Contribution to journal › Article